Compounds > ciglitazone
Page last updated: 2024-10-25

ciglitazone and Hemolysis

ciglitazone has been researched along with Hemolysis in 1 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Niemoeller, OM1
Mahmud, H1
Föller, M1
Wieder, T1
Lang, F1

Other Studies

1 other study available for ciglitazone and Hemolysis

ArticleYear
Ciglitazone and 15d-PGJ2 induced suicidal erythrocyte death.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2008, Volume: 22, Issue:1-4

    Topics: Aniline Compounds; Annexin A5; Calcium; Cell Death; Erythrocytes; Hemolysis; Humans; Prostaglandin D

2008